| E7249 |
Ulinastatin
|
Ulinastatin (Uristatin) is the main inhibitor of a hydrolase protein and serine protease suppresses trypsin, chymotrypsin, and other pancreatic proteases. It can inhibit the production and release of inflammatory factors through mediating inflammatory pathways, while modulating apoptosis, enzyme activity, coagulation, and immune responses. It is effective in preventing and managing conditions like pancreatitis, cerebral edema, acute respiratory distress, circulatory failure, sepsis, and systemic inflammatory response syndrome.
|
|
|
| S0042 |
Fulacimstat
|
Fulacimstat (BAY1142524) is an orally available inhibitor of chymase with IC50 of 4 nM and 3 nM for human and hamster chymase enzyme, respectively.
|
|
|
| S3511 |
FOY251
|
FOY251, an active metabolite of camostat mesilate, is an inhibitor of synthetic serine protease. This compound inhibits SARS-CoV-2 infection.
|
|
|
| E1342 |
Sebetralstat
|
Sebetralstat(KVD900) is a plasma kallikrien inhibitor.
|
|
|
| E6013 |
Sivelestat sodium
|
Sivelestat sodium (ONO-5046, Sodium sivelestat, LY544349 sodium) is a potent, specific, and intravenously active inhibitor of neutrophil elastase with an IC50 value of 44 nm. It is a useful agent for studying the roles of neutrophil elastase in animal disease models such as emphysema, adult respiratory distress syndrome, septic shock and disseminated intravascular coagulation in COVID-19.
|
|
|
| E1014 |
Upamostat (WX-671)
|
Upamostat (WX-671), a novel serine protease urokinase (uPA) inhibitor by inhibiting the urokinase-type plasminogen activator (uPA) system.
|
|
|
| S0479 |
ZK824859
|
ZK824859 is a potent, selective and orally bioavailable inhibitor of urokinase plasminogen activator (uPA) with IC50 of 79 nM, 1580 nM and 1330 nM for human uPA, tPA, and plasmin, respectively.
|
|
|
| S1811 |
Amiloride HCl
|
Amiloride HCl is a selective T-type calcium channel blocker, an epithelial sodium channel blocker and a selective inhibitor of urokinase plasminogen activator (uPA)(Ki=7 μM).
|
-
J Extracell Vesicles, 2024, 13(4):e12426
-
Virus Res, 2024, 339:199258
-
J Clin Invest, 2023, 10.1172/JCI163402
|
|